CLIENT 1ST ADVISORY GROUP, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1802816 DUNEDIN, FL

Position in GILD

as of Jun 30, 2026 · filed Jul 13, 2026 Compact

Position Value

$216,925

-$6,067 QoQ

Shares Held

1,717

+7.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.39%

of 13F equity value

Holder Rank

#1,878

of 2,266 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

CLIENT 1ST ADVISORY GROUP, LLC holds $3,303,980 across 5 Drug Manufacturers - General names. GILD ranks #5 (6.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	1,705	$2,045,028
2	JNJ	Johnson & Johnson	1,743	$442,669
3	ABBV	AbbVie Inc.	1,264	$318,072
4	MRK	Merck & Co., Inc.	2,189	$281,286
5	GILD	Gilead Sciences, Inc. This page	1,717	$216,925

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$216,925	1,717	+7.3%	Shares	Sole	2026-07-13
2026-03-31	$222,992	1,600	—	Shares	Sole	2026-04-15
No filing history on record for this holder in this stock.